{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:17:40Z","timestamp":1707524260247},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,22]]},"DOI":"10.7759\/cureus.16556","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T12:57:56Z","timestamp":1626958676000},"source":"Crossref","is-referenced-by-count":0,"title":["Hyponatremia: An Untimely Finding in Ovarian Hyper-Stimulation Syndrome"],"prefix":"10.7759","author":[{"given":"Mohammed","family":"Elmahal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petras","family":"Lohana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Anvekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj K","family":"Menda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arti","family":".","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-10-32","article-title":"Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment","volume":"10","author":"Fiedler K","year":"2012","unstructured":"Fiedler K, Ezcurra D. Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reprod Biol Endocrinol. 2012, 10:32. 10.1186\/1477-7827-10-32","journal-title":"Reprod Biol Endocrinol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2011.01.014","article-title":"Update on management of ovarian hyperstimulation syndrome","volume":"50","author":"Chen CD","year":"2011","unstructured":"Chen CD, Wu MY, Chao KH, Lien YR, Chen SU, Yang YS. Update on management of ovarian hyperstimulation syndrome. Taiwan J Obstet Gynecol. 2011, 50:2-10. 10.1016\/j.tjog.2011.01.014","journal-title":"Taiwan J Obstet Gynecol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmg005","article-title":"Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS)","volume":"9","author":"Delvigne A","year":"2003","unstructured":"Delvigne A, Rozenberg S. Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Hum Reprod Update. 2003, 9:77-96. 10.1093\/humupd\/dmg005","journal-title":"Hum Reprod Update"},{"key":"ref4","unstructured":"Clinical practice guideline. ovarian hyperstimulation syndrome (OHSS), diagnosis and management. (2014). Accessed: April 1, 2014: https:\/\/www.hse.ie\/eng\/about\/who\/acute-hospitals-division\/woman-infants\/clinical-guidelines\/ovarian-hyperstimulation-...."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.08.034","article-title":"Ovarian hyperstimulation syndrome","volume":"90 (5 Suppl)","author":"Practice Committee of American Society for Reproductive Medicine","year":"2008","unstructured":"Practice Committee of American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril. 2008, 90 (5 Suppl):S188-93. 10.1016\/j.fertnstert.2008.08.034","journal-title":"Fertil Steril"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s1701-2163(16)35085-X","article-title":"The diagnosis and management of ovarian hyperstimulation syndrome","volume":"33","author":"Shmorgun D","year":"2011","unstructured":"Shmorgun D, Claman P, Joint SOGC-CFAS Clinical Practice Guidelines Committee. The diagnosis and management of ovarian hyperstimulation syndrome. J Obstet Gynaecol Can. 2011, 33:1156-62. 10.1016\/s1701-2163(16)35085-X","journal-title":"J Obstet Gynaecol Can"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/3.3.255","article-title":"The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome","volume":"3","author":"Rizk B","year":"1997","unstructured":"Rizk B, Aboulghar M, Smitz J, Ron-El R. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. Hum Reprod Update. 1997, 3:255-66. 10.1093\/humupd\/3.3.255","journal-title":"Hum Reprod Update"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-010-9387-6","article-title":"Ovarian hyperstimulation syndrome: pathophysiology and prevention","volume":"27","author":"Nastri CO","year":"2010","unstructured":"Nastri CO, Ferriani RA, Rocha IA, Martins WP. Ovarian hyperstimulation syndrome: pathophysiology and prevention. J Assist Reprod Genet. 2010, 27:121-8. 10.1007\/s10815-010-9387-6","journal-title":"J Assist Reprod Genet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008046.pub4","article-title":"Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology","author":"Youssef MA","year":"2014","unstructured":"Youssef MA, Van der Veen F, Al-Inany HG, et al.. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. Cochrane Database Syst Rev. 2014, CD008046. 10.1002\/14651858.CD008046.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref10","article-title":"Ovarian hyperstimulation syndrome: current views on pathophysiology, risk factors, prevention, and management","volume":"6","author":"Alper MM","year":"2009","unstructured":"Alper MM, Smith LP, Sills ES. Ovarian hyperstimulation syndrome: current views on pathophysiology, risk factors, prevention, and management. J Exp Clin Assist Reprod. 2009, 6:3.","journal-title":"J Exp Clin Assist Reprod"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dem254","article-title":"Serum anti-M\u00fcllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles","volume":"23","author":"Lee TH","year":"2008","unstructured":"Lee TH, Liu CH, Huang CC, et al.. Serum anti-M\u00fcllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum Reprod. 2008, 23:160-7. 10.1093\/humrep\/dem254","journal-title":"Hum Reprod"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.12.003","article-title":"Renin-angiotensin system activation during severe OHSS: cause or effect?","volume":"89","author":"Manno M","year":"2008","unstructured":"Manno M, Tomei F. Renin-angiotensin system activation during severe OHSS: cause or effect?. Fertil Steril. 2008, 89:488. 10.1016\/j.fertnstert.2007.12.003","journal-title":"Fertil Steril"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/64482-hyponatremia-an-untimely-finding-in-ovarian-hyper-stimulation-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:28:04Z","timestamp":1707506884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/64482-hyponatremia-an-untimely-finding-in-ovarian-hyper-stimulation-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.16556","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,22]]}}}